Literature DB >> 12652465

Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience.

David Gómez-Almaguer1, Guillermo J Ruiz-Argüelles, Luz del Carmen Tarín-Arzaga, Oscar González-Llano, José Carlos Jaime-Pérez, Briceida López-Martínez, Olga G Cantú-Rodríguez, José Luis Herrera-Garza.   

Abstract

A group of 21 consecutive patients aged 4-20 (median 13) years was prospectively allografted using a reduced intensity preparative regimen. The group included both malignant (acute lymphoblastic leukemia, acute myelogenous leukemia, and chronic myelogenous leukemia) and nonmalignant (aplastic anemia, Diamond-Blackfan anemia, thalassemia major and adrenoleukodystrophy) conditions. Follow-up times ranged between 16 and 1038 days. Four of 21 patients (9.5%) developed acute graft-versus-host disease, and 2 of them died, whereas limited chronic graft-versus-host disease was observed in 2 of 15 cases. The 100-day mortality was 19%. Median overall survival was above 1038 days, whereas the 34-month survival was 55%. These data show that reduced intensity stem cell transplantation in children permits rapid engraftment from siblings with little toxicity. Copyright 2003 American Society for Blood and Marrow Transplantation

Entities:  

Mesh:

Year:  2003        PMID: 12652465     DOI: 10.1053/bbmt.2003.50004

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  5 in total

1.  The Mexican approach to conduct nonmyeloablative stem cell transplantation should not be overlooked.

Authors:  Guillermo J Ruiz-Argüelles; David Gómez-Almaguer
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

2.  Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP.

Authors:  A Lawitschka; M Faraci; I Yaniv; P Veys; P Bader; J Wachowiak; G Socie; M D Aljurf; M Arat; J J Boelens; R Duarte; A Tichelli; C Peters
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

3.  Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico.

Authors:  José Carlos Jaime-Pérez; Alberto Carlos Heredia-Salazar; Olga G Cantú-Rodríguez; Homero Gutiérrez-Aguirre; César Daniel Villarreal-Villarreal; Consuelo Mancías-Guerra; José Luís Herrera-Garza; David Gómez-Almaguer
Journal:  Oncologist       Date:  2015-03-06

4.  Survival after cord blood transplantation from unrelated donor as a second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.

Authors:  M Oda; K Isoyama; E Ito; M Inoue; M Tsuchida; H Kigasawa; K Kato; S Kato
Journal:  Int J Hematol       Date:  2009-03-18       Impact factor: 2.490

5.  Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.

Authors:  Adrianna Vlachos; Sarah Ball; Niklas Dahl; Blanche P Alter; Sujit Sheth; Ugo Ramenghi; Joerg Meerpohl; Stefan Karlsson; Johnson M Liu; Thierry Leblanc; Carole Paley; Elizabeth M Kang; Eva Judmann Leder; Eva Atsidaftos; Akiko Shimamura; Monica Bessler; Bertil Glader; Jeffrey M Lipton
Journal:  Br J Haematol       Date:  2008-07-30       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.